Belmina Michael, MD
Dermatology · Forest Park, ILNPI 1063451458
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 138 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 29.5% of the total. 2025 is the largest year on record at $859, 2.9 times the $295 reported in 2019.
Across 138 payments — averaging $22.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$925
- Amgen$451
- UCB, Inc.$309
- Lilly USA, LLC$193
- Novartis$188
- Mayne Pharma Commercial LLC$184
- plus $886 from 12 others
What the payments were for
- Food & beverage$3,11999%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 42 | $925 |
| Amgen | 23 | $451 |
| UCB, Inc. | 11 | $309 |
| Lilly USA, LLC | 8 | $193 |
| Novartis | 10 | $188 |
| Mayne Pharma Commercial LLC | 5 | $184 |
| Pfizer | 8 | $157 |
| LEO Pharma Inc. | 9 | $150 |
| Sun Pharmaceutical Industries Inc. | 5 | $125 |
| Urovant Sciences Inc | 1 | $124 |
| Johnson & Johnson | 3 | $74 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| Bristol Myers Squibb | 2 | $49 |
| Arcutis Biotherapeutics, Inc. | 2 | $30 |
| Boehringer Ingelheim | 1 | $29 |
| Melinta Therapeutics, LLC | 2 | $29 |
| Merck | 2 | $28 |
| Galderma Laboratories, L.p. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,136 in reported general payments places this provider in the 55th percentile of 606 dermatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 191 | $4,141 |
| Betamethasone Dipropionate | 78 | $4,122 |
| Fluorouracil | 17 | $2,624 |
| Mupirocin | 230 | $2,399 |
| Ketoconazole | 111 | $1,308 |
| Gentamicin Sulfate | 27 | $1,094 |
| Sulfacetamide Sodium | 11 | $1,084 |
| Cephalexin | 120 | $1,079 |
| Fluocinonide | 19 | $991 |
| Doxycycline Hyclate | 24 | $897 |
| Triamcinolone Acetonide | 35 | $370 |
| ValacyclovirValacyclovir Hcl | 18 | $333 |
| Azithromycin | 40 | $212 |
| Hydrocortisone | 34 | $160 |
| Amoxicillin | 39 | $54 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Forest Park
- Ahmad AminNaperville$4.1M
- Raj ChovatiyaChicago$3.6M
- George LewittNorthbrook$3M
- Peter LioChicago$2.4M
- Elizabeth KiracofeChicago$1.6M
- Lana SchmidtEffingham$1.3M
- Melissa AbramsVernon Hills$600K
- Carolyn JacobChicago$566K
- Walter LiszewskiChicago$414K
- Emily RubensteinLincolnshire$359K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.